Omeros’ narsoplimab pivotal trial data shared in oral presentation at annual european hematology association congress

Omeros corporation (nasdaq: omer) today announced that the results of its pivotal trial of narsoplimab in the treatment of hematopoietic stem cell tra

OMER Ratings Summary

OMER Quant Ranking